A retrospective observational study to assess drug utilization of Glucagon-Like Peptide-1 Receptor Agonist in Type 2 Diabetes patients in Japan
Latest Information Update: 21 Dec 2020
At a glance
- Drugs Dulaglutide (Primary) ; Exenatide (Primary) ; Liraglutide (Primary) ; Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Dec 2020 New trial record